BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 16750852)

  • 1. Detection of hematopoietic maturation abnormalities by flow cytometry in myelodysplastic syndromes and its utility for the differential diagnosis with non-clonal disorders.
    Lorand-Metze I; Ribeiro E; Lima CS; Batista LS; Metze K
    Leuk Res; 2007 Feb; 31(2):147-55. PubMed ID: 16750852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression of differentiation antigens on bone marrow myeloid cells of the patients with myelodysplastic syndromes and its clinical significances].
    Li LJ; Fu R; Wang HQ; Yue LZ; Liu H; Wang J; Wang HL; Ruan EB; Qu W; Liang Y; Wang GJ; Wang XM; Liu H; Song J; Wu YH; Xing LM; Guan J; Shao ZH
    Zhonghua Yi Xue Za Zhi; 2010 Mar; 90(10):672-7. PubMed ID: 20450725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A combination of CD15/CD10, CD64/CD33, CD16/CD13 or CD11b flow cytometric granulocyte panels is sensitive and specific for diagnosis of myelodysplastic syndrome.
    Chung JW; Park CJ; Cha CH; Cho YU; Jang S; Chi HS; Seo EJ; Lee JH; Lee JH; Lee KH; Im HJ; Seo JJ
    Ann Clin Lab Sci; 2012; 42(3):271-80. PubMed ID: 22964615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral blood MDS score: a new flow cytometric tool for the diagnosis of myelodysplastic syndromes.
    Cherian S; Moore J; Bantly A; Vergilio JA; Klein P; Luger S; Bagg A
    Cytometry B Clin Cytom; 2005 Mar; 64(1):9-17. PubMed ID: 15668954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased immature hematopoietic progenitor cells CD34+/CD38dim in myelodysplasia.
    Monreal MB; Pardo ML; Pavlovsky MA; Fernandez I; Corrado CS; Giere I; Sapia S; Pavlovsky S
    Cytometry B Clin Cytom; 2006 Mar; 70(2):63-70. PubMed ID: 16470534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flow cytometry in myelodysplastic syndrome: analysis of diagnostic utility using maturation pattern-based and quantitative approaches.
    Chopra A; Pati H; Mahapatra M; Mishra P; Seth T; Kumar S; Singh S; Pandey S; Kumar R
    Ann Hematol; 2012 Sep; 91(9):1351-62. PubMed ID: 22526362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maturation-associated immunophenotypic abnormalities in bone marrow B-lymphocytes in myelodysplastic syndromes.
    Ribeiro E; Matarraz Sudón S; de Santiago M; Lima CS; Metze K; Giralt M; Saad ST; de Matos AO; Lorand-Metze I
    Leuk Res; 2006 Jan; 30(1):9-16. PubMed ID: 16005514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GATA-1 transcription factor is up-regulated in bone marrow hematopoietic progenitor CD34(+) and erythroid CD71(+) cells in myelodysplastic syndromes.
    Maratheftis CI; Bolaraki PE; Voulgarelis M
    Am J Hematol; 2007 Oct; 82(10):887-92. PubMed ID: 17570514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving the differential diagnosis between myelodysplastic syndromes and reactive peripheral cytopenias by multiparametric flow cytometry: the role of B-cell precursors.
    Reis-Alves SC; Traina F; Metze K; Lorand-Metze I
    Diagn Pathol; 2015 Apr; 10():44. PubMed ID: 25924846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunophenotypic features of granulocytes, monocytes, and blasts in myelodysplastic syndromes.
    Moon HW; Huh JW; Lee M; Hong KS; Chung WS
    Korean J Lab Med; 2010 Apr; 30(2):97-104. PubMed ID: 20445324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic value of maturation-associated phenotypic abnormalities in myelodysplastic syndromes.
    Lorand-Metze I; Califani SM; Ribeiro E; Lima CS; Metze K
    Leuk Res; 2008 Feb; 32(2):211-3. PubMed ID: 17675154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiparameter flow cytometric analysis reveals low percentage of bone marrow hematogones in myelodysplastic syndromes.
    Maftoun-Banankhah S; Maleki A; Karandikar NJ; Arbini AA; Fuda FS; Wang HY; Chen W
    Am J Clin Pathol; 2008 Feb; 129(2):300-8. PubMed ID: 18208811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flow-cytometric analysis of peripheral blood neutrophils: a simple, objective, independent and potentially clinically useful assay to facilitate the diagnosis of myelodysplastic syndromes.
    Cherian S; Moore J; Bantly A; Vergilio JA; Klein P; Luger S; Bagg A
    Am J Hematol; 2005 Jul; 79(3):243-5. PubMed ID: 15981222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flow cytometric scoring system (FCMSS) assisted diagnosis of myelodysplastic syndromes (MDS) and the biological significance of FCMSS-based immunophenotypes.
    Xu F; Li X; Wu L; He Q; Zhang Z; Chang C
    Br J Haematol; 2010 May; 149(4):587-97. PubMed ID: 20331463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for expression of early myeloid antigens in mature, non-blast myeloid cells in myelodysplasia.
    Xu D; Schultz C; Akker Y; Cannizzaro L; Ramesh KH; Du J; Ratech H
    Am J Hematol; 2003 Sep; 74(1):9-16. PubMed ID: 12949884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Qualitative flow cytometric analysis of Malaysian myelodysplastic syndromes (MDS) patients.
    Mohadese Hashem B; Rajesh R; Sabariah MN; Zainina BS
    Med J Malaysia; 2012 Feb; 67(1):77-80. PubMed ID: 22582553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone marrow cells from myelodysplastic syndromes show altered immunophenotypic profiles that may contribute to the diagnosis and prognostic stratification of the disease: a pilot study on a series of 56 patients.
    Matarraz S; López A; Barrena S; Fernandez C; Jensen E; Flores-Montero J; Rasillo A; Sayagues JM; Sánchez ML; Bárcena P; Hernandez-Rivas JM; Salvador C; Fernandez-Mosteirín N; Giralt M; Perdiguer L; Laranjeira P; Paiva A; Orfao A
    Cytometry B Clin Cytom; 2010 May; 78(3):154-68. PubMed ID: 20198685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunophenotypic characterization of myelopoiesis in early and late myelodysplastic syndromes: use of CD44 as an aid in early diagnosis.
    Karmon Y; Manaster J; Chezar J
    Cytometry; 2002 Aug; 50(4):225-30. PubMed ID: 12210602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flow cytometric scoring system as a diagnostic and prognostic tool in myelodysplastic syndromes.
    Chu SC; Wang TF; Li CC; Kao RH; Li DK; Su YC; Wells DA; Loken MR
    Leuk Res; 2011 Jul; 35(7):868-73. PubMed ID: 21397943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Preliminary study of biological characteristics of myelodysplastic syndromes clonal cells].
    Li X; Wu LY; Ying SX; Chang CK; He Q; Song LQ; Pu Q
    Zhonghua Xue Ye Xue Za Zhi; 2007 Jul; 28(7):478-83. PubMed ID: 18072633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.